Physician profile
Timothy Greene
NPI 1578946182
$19,511.60
in general payments reported to CMS, 2019-2025
38 companies · $1,082 in 2025
The $1,082 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,137 · 2020: $1,000 · 2021: $3,416 · 2022: $8,037 · 2023: $3,032 · 2024: $1,807 · 2025: $1,082.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,621 · Travel and Lodging: $1,300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,621.20 |
| Travel and Lodging | $1,300.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $6,791.80 | 2022-2023 | |
| Stryker Corporation | $2,751.48 | 2021-2025 | Prostep, Citrefix, Hoffmann |
| Paragon 28, INC. | $1,490.21 | 2019-2024 | Phantom Hindfoot, Portfolio |
| Smith+Nephew, INC. | $1,487.61 | 2019-2025 | Collagenase Santyl, Stravix, Grafix Pl |
| Empire Medical, INC | $1,396.94 | 2022-2023 | |
| Vilex LLC | $1,166.32 | 2021 | |
| Treace Medical Concepts, INC. | $766.80 | 2024-2025 | |
| Paratek Pharmaceuticals, INC. | $481.56 | 2021-2024 | Nuzyra |
| Horizon Therapeutics Plc | $465.98 | 2020-2023 | Krystexxa |
| Grt US Holding, INC. | $417.06 | 2021-2022 | |
| Integra Lifesciences Corporation | $265.79 | 2019-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Koya Medical, INC. | $245.50 | 2024 | Dayspring, Koya Medical |
| Medshape, INC. | $190.46 | 2024 | Dynanail |
| Abbvie INC. | $175.41 | 2021-2024 | |
| Averitas Pharma INC. | $173.14 | 2023-2025 | Qutenza |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $151.78 | 2021-2023 | |
| Cumberland Pharmaceuticals, INC. | $141.19 | 2020-2022 | |
| Theratechnologies INC. | $107.06 | 2022-2024 | Trogarzo, Egrifta |
| Fusion Orthopedics USA, LLC | $89.50 | 2024 | |
| Bioventus LLC | $88.09 | 2020-2024 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Ferring Pharmaceuticals INC. | $79.56 | 2022 | |
| Janssen Scientific Affairs, LLC | $76.50 | 2022 | |
| Tactile Systems Technology INC | $69.92 | 2019-2022 | |
| In2bones USA, LLC | $54.15 | 2020 | |
| Alfasigma USA, INC. | $49.98 | 2020-2022 | |
| Melinta Therapeutics, LLC | $43.75 | 2020 | |
| Assertio Therapeutics, INC. | $40.96 | 2020 | |
| Acera Surgical, INC. | $39.93 | 2020-2022 | |
| La Jolla Pharmaceutical Company | $29.78 | 2022 | |
| Davol INC. | $29.56 | 2021 | |
| Trimed, INC. | $26.56 | 2024 | |
| Medtronic, INC. | $26.02 | 2024 | Intellis Adaptivestim |
| Djo, LLC | $25.41 | 2019 | |
| Nevro Corp. | $20.79 | 2022 | |
| Merck Sharp & Dohme LLC | $18.69 | 2021 | |
| Allergan, INC. | $17.25 | 2020 | |
| Acell, INC. | $11.72 | 2019 | |
| Amniox Medical, INC. | $7.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Greene listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.